Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Product Information
The FDA has classified it as a Category 2 bulk drug substance, and WADA has banned it
Following the nerve transection, heparin was delivered through the tail vein and the animal was monitored under anesthesia for an hour to simulate the transport time it takes to get treatment in cases of traumatic peripheral nerve damage
The peptide has never been tested on humans except for one small trial that was never published
Over the past 20 years, a few dozen preclinical studies (meaning research conducted in animals or cells and not in human trials) have yielded potentially promising data suggesting that the peptide can fight inflammation and promote protein synthesis and angiogenesis (the fancy scientific term for the process by which your body produces new blood vessels)
Researchers sought to improve upon earlier amylin-based compounds by extending duration of action and enhancing pharmacological stability
